Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qiagen NV's share price for the quarter that ended in Dec. 2023 was $44.7732. Qiagen NV's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 221 Mil. Therefore, Qiagen NV's market cap for the quarter that ended in Dec. 2023 was $9,911 Mil.
Qiagen NV's quarterly market cap
declined
from Jun. 2023 ($10,275 Mil) to Sep. 2023 ($9,241 Mil) but then
increased
from Sep. 2023 ($9,241 Mil) to Dec. 2023 ($9,911 Mil).
Qiagen NV's annual market cap
declined
from Dec. 2021 ($12,621 Mil) to Dec. 2022 ($11,356 Mil) and
declined
from Dec. 2022 ($11,356 Mil) to Dec. 2023 ($9,911 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qiagen NV's Enterprise Value for Today is $9,694 Mil.
Qiagen NV Market Cap Historical Data
The historical data trend for Qiagen NV's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Qiagen NV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Market Cap distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Market Cap falls into.
Qiagen NV Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Qiagen NV's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (NYSE:QGEN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Qiagen NV Market Cap Related Terms
Thank you for viewing the detailed overview of Qiagen NV's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
QGEN has been successfully added to your 